SKYMAX LIFESCIENCE PRIVATE LTD.
The SKYMAX team comprises young Pharma technocrats, management professionals, and dynamic marketers who collectively bring Vision, R&D Capabilities, Technological Expertise, Quality Innovation, and Manufacturing Proficiency to the company. With a youthful and enthusiastic board of directors, SKYMAX aims to establish itself as a global pharmaceutical leader by 2020. Dedicated to maximizing healthcare, the company endeavors to significantly enhance the quality of life for people worldwide. SKYMAX offers a diverse range of products and delivery systems spanning various segments including Antibiotics, Anti-inflammatory, Anti-emetic, Antimalarial, Anti-diarrheal, Anti-protozoal, and specialized products catering to Gastroenterologists, Gynecologists, Orthopedic, and Cardio-diabetic specialists.
